CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency

被引：121

作者：

Bidinosti, Michael ^{[1
]}

Botta, Paolo ^{[3
]}

Kruttner, Sebastian ^{[3
]}

Proenca, Catia C. ^{[1
]}

Stoehr, Natacha ^{[1
]}

Bernhard, Mario ^{[1
]}

Fruh, Isabelle ^{[1
]}

Mueller, Matthias ^{[1
]}

Bonenfant, Debora ^{[2
]}

Voshol, Hans ^{[2
]}

Carbone, Walter ^{[1
]}

Neal, Sarah J. ^{[4
]}

McTighe, Stephanie M. ^{[4
]}

Roma, Guglielmo ^{[1
]}

Dolmetsch, Ricardo E. ^{[4
]}

Porter, Jeffrey A. ^{[1
]}

Caroni, Pico ^{[3
]}

Bouwmeester, Tewis ^{[1
]}

Luthi, Andreas ^{[3
]}

Galimberti, Ivan ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Dev Mol Pathways, Basel, Switzerland

[2] Novartis Inst Biomed Res, Analyt Sci & Imaging, Basel, Switzerland

[3] Friedrich Miescher Inst, Basel, Switzerland

[4] Novartis Inst Biomed Res, Neurosci, Cambridge, MA USA

来源：

SCIENCE | 2016年 / 351卷 / 6278期

关键词：

SCAFFOLDING PROTEIN SHANK3; GROWTH-FACTOR-I; MUTATIONS; MICE; EXPRESSION; BEHAVIORS; ISOFORMS; FAMILY;

D O I：

10.1126/science.aad5487

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

SH3 and multiple ankyrin repeat domains 3 (SHANK3) haploinsufficiency is causative for the neurological features of Phelan-McDermid syndrome (PMDS), including a high risk of autism spectrum disorder (ASD). We used unbiased, quantitative proteomics to identify changes in the phosphoproteome of Shank3-deficient neurons. Down-regulation of protein kinase B (PKB/Akt)-mammalian target of rapamycin complex 1 (mTORC1) signaling resulted from enhanced phosphorylation and activation of serine/threonine protein phosphatase 2A (PP2A) regulatory subunit, B56b, due to increased steady-state levels of its kinase, Cdc2-like kinase 2 (CLK2). Pharmacological and genetic activation of Akt or inhibition of CLK2 relieved synaptic deficits in Shank3-deficient and PMDS patient-derived neurons. CLK2 inhibition also restored normal sociability in a Shank3-deficient mouse model. Our study thereby provides a novel mechanistic and potentially therapeutic understanding of deregulated signaling downstream of Shank3 deficiency.

引用

页码：1199 / 1203

页数：5

共 27 条

[1] Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay
Bozdagi, Ozlem
Tavassoli, Teresa
Buxbaum, Joseph D.
[J]. MOLECULAR AUTISM, 2013, 4
[2] Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication
Bozdagi, Ozlem
Sakurai, Takeshi
Papapetrou, Danae
Wang, Xiaobin
Dickstein, Dara L.
Takahashi, Nagahide
Kajiwara, Yuji
Yang, Mu
Katz, Adam M.
Scattoni, Maria Luisa
Harris, Mark J.
Saxena, Roheeni
Silverman, Jill L.
Crawley, Jacqueline N.
Zhou, Qiang
Hof, Patrick R.
Buxbaum, Joseph D.
[J]. MOLECULAR AUTISM, 2010, 1
[3] Impairment of TrkB-PSD-95 Signaling in Angelman Syndrome
Cao, Cong
Rioult-Pedotti, Mengia S.
Migani, Paolo
Yu, Crystal J.
Tiwari, Rakesh
Parang, Keykavous
Spaller, Mark R.
Goebel, Dennis J.
Marshall, John
[J]. PLOS BIOLOGY, 2013, 11 (02):
[4] Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators
Duffney, Lara J.
Zhong, Ping
Wei, Jing
Matas, Emmanuel
Cheng, Jia
Qin, Luye
Ma, Kaijie
Dietz, David M.
Kajiwara, Yuji
Buxbaum, Joseph D.
Yan, Zhen
[J]. CELL REPORTS, 2015, 11 (09): : 1400 - 1413
[5] Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Durand, Christelle M.
Betancur, Catalina
Boeckers, Tobias M.
Bockmann, Juergen
Chaste, Pauline
Fauchereau, Fabien
Nygren, Gudrun
Rastam, Maria
Gillberg, I. Carina
Anckarsater, Henrik
Sponheim, Eili
Goubran-Botros, Hany
Delorme, Richard
Chabane, Nadia
Mouren-Simeoni, Marie-Christine
de Mas, Philippe
Bieth, Eric
Roge, Bernadette
Heron, Delphine
Burglen, Lydie
Gillberg, Christopher
Leboyer, Marion
Bourgeron, Thomas
[J]. NATURE GENETICS, 2007, 39 (01) : 25 - 27
[6] De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Gauthier, Julie
Champagne, Nathalie
Lafreniere, Ronald G.
Xiong, Lan
Spiegelman, Dan
Brustein, Edna
Lapointe, Mathieu
Peng, Huashan
Cote, Melanie
Noreau, Anne
Hamdan, Fadi F.
Addington, Anjene M.
Rapoport, Judith L.
DeLisi, Lynn E.
Krebs, Marie-Odile
Joober, Ridha
Fathalli, Ferid
Mouaffak, Faycal
Haghighi, Ali P.
Neri, Christian
Dube, Marie-Pierre
Samuels, Mark E.
Marineau, Claude
Stone, Eric A.
Awadalla, Philip
Barker, Philip A.
Carbonetto, Salvatore
Drapeau, Pierre
Rouleau, Guy A.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (17) : 7863 - 7868
[7] PTEN mutation in a family with Cowden syndrome and autism
Goffin, A
Hoefsloot, LH
Bosgoed, E
Swillen, A
Fryns, JP
[J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (06): : 521 - 524
[8] Conversion of a Single Polypharmacological Agent into Selective Bivalent Inhibitors of Intracellular Kinase Activity
Gower, Carrie M.
Thomas, Jason R.
Harrington, Edmund
Murphy, Jason
Chang, Matthew E. K.
Cornella-Taracido, Ivan
Jain, Rishi K.
Schirle, Markus
Maly, Dustin J.
[J]. ACS CHEMICAL BIOLOGY, 2016, 11 (01) : 121 - 131
[9] SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties
Han, Kihoon
Holder, J. Lloyd, Jr.
Schaaf, Christian P.
Lu, Hui
Chen, Hongmei
Kang, Hyojin
Tang, Jianrong
Wu, Zhenyu
Hao, Shuang
Cheung, Sau Wai
Yu, Peng
Sun, Hao
Breman, Amy M.
Patel, Ankita
Lu, Hui-Chen
Zoghbi, Huda Y.
[J]. NATURE, 2013, 503 (7474) : 72 - +
[10] Modeling Autism by SHANK Gene Mutations in Mice
Jiang, Yong-hui
Ehlers, Michael D.
[J]. NEURON, 2013, 78 (01) : 8 - 27

← 1 2 3 →